Company Filing History:
1 out of 15,475 
1 out of 4,455 
Years Active: 2021
Title: Thomas Mikita: Innovator in Antibody Research
Introduction
Thomas Mikita is a prominent inventor based in Sausalito, California. He has made significant contributions to the field of biomedical research, particularly in the development of antibodies targeting coagulation factors. His innovative work has implications for the prevention and treatment of thrombotic diseases.
Latest Patents
Thomas Mikita holds a patent for "Antibodies to coagulation factor XIa and uses thereof." This patent includes antibodies that specifically bind to activated Factor XI (FXIa). The patent also outlines methods for obtaining these antibodies and the nucleic acids encoding them. Additionally, it provides compositions and therapeutic methods for preventing thrombotic diseases, disorders, or conditions. The patent emphasizes the importance of anti-idiotype antibodies that bind to the anti-FXIa antibodies disclosed.
Career Highlights
Throughout his career, Thomas Mikita has worked with esteemed organizations such as the University of California and Pfizer Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Thomas Mikita's notable coworkers include Lauren K Ely and Huilan Gao. Their collaborative efforts have further advanced the research and development of therapeutic antibodies.
Conclusion
Thomas Mikita's innovative work in antibody research has the potential to significantly impact the treatment of thrombotic diseases. His contributions to the field exemplify the importance of scientific innovation in improving healthcare outcomes.